Aristotle Capital Boston Cut Holding in On Assignment (ASGN) as Share Price Rose; Broadfin Capital Position In Angiodynamics (ANGO) Was Has Boosted

February 16, 2018 - By Dolores Ford

Aristotle Capital Boston Llc decreased its stake in On Assignment Inc (ASGN) by 6.97% based on its latest 2017Q3 regulatory filing with the SEC. Aristotle Capital Boston Llc sold 28,651 shares as the company’s stock rose 6.65% with the market. The institutional investor held 382,624 shares of the technology company at the end of 2017Q3, valued at $20.54 million, down from 411,275 at the end of the previous reported quarter. Aristotle Capital Boston Llc who had been investing in On Assignment Inc for a number of months, seems to be less bullish one the $3.94B market cap company. The stock increased 0.30% or $0.23 during the last trading session, reaching $75.73. About 147,189 shares traded. On Assignment, Inc. (NYSE:ASGN) has risen 41.91% since February 16, 2017 and is uptrending. It has outperformed by 25.21% the S&P500.

Kevin Kotler increased its stake in Angiodynamics Inc (ANGO) by 5.21% based on its latest 2017Q3 regulatory filing with the SEC. Broadfin Capital Llc bought 87,688 shares as the company’s stock declined 6.23% while stock markets rallied. The hedge fund run by Kevin Kotler held 1.77M shares of the health care company at the end of 2017Q3, valued at $30.27M, up from 1.68M at the end of the previous reported quarter. Broadfin Capital Llc who had been investing in Angiodynamics Inc for a number of months, seems to be bullish on the $608.87M market cap company. The stock increased 0.91% or $0.15 during the last trading session, reaching $16.57. About 30,109 shares traded. AngioDynamics, Inc. (NASDAQ:ANGO) has risen 31.47% since February 16, 2017 and is uptrending. It has outperformed by 14.77% the S&P500.




Investors sentiment increased to 1.05 in Q3 2017. Its up 0.07, from 0.98 in 2017Q2. It is positive, as 15 investors sold ASGN shares while 71 reduced holdings. 29 funds opened positions while 61 raised stakes. 45.80 million shares or 1.59% less from 46.54 million shares in 2017Q2 were reported. Ftb Inc invested in 0% or 346 shares. Piedmont Investment Advisors Ltd Liability holds 0.01% or 10,812 shares in its portfolio. Ahl Prns Llp reported 0.06% in On Assignment, Inc. (NYSE:ASGN). Legal General Gp Public Ltd Com invested 0% in On Assignment, Inc. (NYSE:ASGN). Farmers And Merchants Invs invested in 0% or 145 shares. First Interstate Bancshares holds 0% or 382 shares. Century Cos owns 0% invested in On Assignment, Inc. (NYSE:ASGN) for 14,750 shares. Hood River Mngmt Limited Liability Co owns 215,950 shares. Etrade Capital Management Ltd Liability Corp accumulated 0.05% or 23,786 shares. First Quadrant Ltd Partnership Ca holds 0% or 3,318 shares. Rice Hall James Assoc Limited Liability Company holds 1.25% or 526,309 shares. Proshare Advisors Ltd Limited Liability Company accumulated 0% or 4,458 shares. Northern Tru Corporation stated it has 0.01% in On Assignment, Inc. (NYSE:ASGN). Laurion Cap Mgmt LP reported 30,856 shares or 0.01% of all its holdings. Bancshares Of Montreal Can reported 3,642 shares stake.

Among 7 analysts covering On Assignment Inc (NYSE:ASGN), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. On Assignment Inc had 32 analyst reports since October 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, July 27 by RBC Capital Markets. The stock has “Buy” rating by RBC Capital Markets on Monday, January 8. The firm earned “Hold” rating on Wednesday, December 9 by Deutsche Bank. RBC Capital Markets maintained On Assignment, Inc. (NYSE:ASGN) rating on Wednesday, October 11. RBC Capital Markets has “Buy” rating and $55.0 target. The firm has “Mkt Perform” rating by Avondale given on Monday, December 19. SunTrust maintained it with “Buy” rating and $80.0 target in Wednesday, January 31 report. The stock of On Assignment, Inc. (NYSE:ASGN) earned “Hold” rating by Robert W. Baird on Friday, September 1. On Thursday, October 26 the stock rating was maintained by Deutsche Bank with “Buy”. The rating was maintained by Avondale on Thursday, April 28 with “Market Outperform”. The firm has “Buy” rating by BMO Capital Markets given on Tuesday, July 11.

Aristotle Capital Boston Llc, which manages about $1.48 billion and $1.12B US Long portfolio, upped its stake in Orbital Atk Inc by 12,608 shares to 87,873 shares, valued at $11.70 million in 2017Q3, according to the filing. It also increased its holding in Cross Ctry Healthcare Inc (NASDAQ:CCRN) by 172,018 shares in the quarter, for a total of 762,200 shares, and has risen its stake in National Bk Hldgs Corp (NYSE:NBHC).

Since October 10, 2017, it had 0 insider purchases, and 7 sales for $17.77 million activity. $1.20M worth of On Assignment, Inc. (NYSE:ASGN) was sold by Callaghan Brian J. on Thursday, October 26. On Friday, October 27 the insider BLAZER RANDOLPH C sold $596,727.

Investors sentiment decreased to 1.17 in Q3 2017. Its down 1.32, from 2.49 in 2017Q2. It dropped, as 13 investors sold ANGO shares while 52 reduced holdings. 24 funds opened positions while 52 raised stakes. 33.36 million shares or 0.00% more from 33.36 million shares in 2017Q2 were reported. Numeric Invsts Ltd Liability Corp owns 708,482 shares. Legal & General Gru Public Lc holds 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO) for 65,557 shares. 95,022 were reported by Capital One Natl Association. Swiss Bancorporation holds 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO) for 61,000 shares. Bnp Paribas Arbitrage stated it has 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO). Capital Fund Sa holds 10,700 shares. Connor Clark & Lunn Investment Management Limited stated it has 0.01% in AngioDynamics, Inc. (NASDAQ:ANGO). Foundry Prtn Lc accumulated 0.27% or 399,400 shares. State Board Of Administration Of Florida Retirement holds 0% of its portfolio in AngioDynamics, Inc. (NASDAQ:ANGO) for 35,168 shares. Strs Ohio invested in 42,800 shares or 0% of the stock. Ls Inv Advsrs Ltd Limited Liability Company invested in 1,331 shares or 0% of the stock. Moreover, Thrivent Financial For Lutherans has 0% invested in AngioDynamics, Inc. (NASDAQ:ANGO). Sentinel Asset Inc reported 824,201 shares stake. California Public Employees Retirement Sys has 196,202 shares for 0% of their portfolio. Convergence Invest Prtn Lc reported 90,909 shares.

Among 8 analysts covering AngioDynamics (NASDAQ:ANGO), 1 have Buy rating, 0 Sell and 7 Hold. Therefore 13% are positive. AngioDynamics had 20 analyst reports since July 24, 2015 according to SRatingsIntel. The rating was maintained by Canaccord Genuity with “Buy” on Friday, January 8. KeyBanc Capital Markets maintained the stock with “Hold” rating in Thursday, September 28 report. The firm has “Hold” rating given on Thursday, August 24 by KeyBanc Capital Markets. Canaccord Genuity maintained AngioDynamics, Inc. (NASDAQ:ANGO) rating on Sunday, October 8. Canaccord Genuity has “Hold” rating and $17.0 target. The rating was reinitiated by Piper Jaffray on Friday, April 8 with “Neutral”. The firm has “Hold” rating given on Friday, January 5 by Craig Hallum. As per Thursday, January 4, the company rating was maintained by Canaccord Genuity. The company was maintained on Monday, September 4 by Canaccord Genuity. The firm has “Hold” rating given on Sunday, August 6 by Canaccord Genuity. Raymond James downgraded AngioDynamics, Inc. (NASDAQ:ANGO) on Tuesday, November 10 to “Mkt Perform” rating.

Broadfin Capital Llc, which manages about $1.26 billion and $676.01 million US Long portfolio, decreased its stake in Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) by 106,992 shares to 74,208 shares, valued at $8.72 million in 2017Q3, according to the filing. It also reduced its holding in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) by 457,500 shares in the quarter, leaving it with 6.89M shares, and cut its stake in Antares Pharma Inc (NASDAQ:ATRS).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.